❤️ Health · The Washington Post
Surprising drug combo could reshape treatment for suicide risk - The Washington Post
From The Washington Post via USVI News: A new study suggests a single ketamine infusion followed by low-dose buprenorphine significantly sustained reductions in suicidal ideation in adults with major depressive disorder.
Modern psychiatry has long struggled with one brutal fact: the people most at risk of suicide often cannot wait weeks for therapy or antidepressants to work. Now, a new study suggests researchers may…
This article is republished through the USVI News affiliate desk. Reporting, analysis, and viewpoints are those of the original publisher and do not necessarily reflect USVI News.